Approval · Notice of Compliance 27429 · 2022
MICRO +4 REGULAR STRENGTH: Notice of Compliance 27429
Issued January 20, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27429
- Date
- January 20, 2022
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Updates to the Product Monograph (PM) in response to an Advisement Letter, and converting the PM to the 2020 Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO +4 REGULAR STRENGTH | 02091135 | Marketed |